II Level Master in International Translational Medicine A.Y. 2026/2027

II Level Master in International Translational Medicine A.Y. 2026/2027

Length2 years
ECTS60
AdmissionQualifications
LanguageEnglish

Master Directors

Chiara Bonini

Full Professor of Hematology at Vita-Salute San Raffaele University and Vice Director of Immunology Research at San Raffaele Scientific Institute. A pioneer in cellular and gene therapy, she has led groundbreaking clinical trials on engineered T cells for cancer and immune disorders. Her work bridges cutting-edge science and patient care, shaping the future of immunotherapy worldwide. With international experience from institutions like Fred Hutchinson and Memorial Sloan Kettering, she is a recognized leader in translational research. Passionate about innovation, Bonini’s research continues to redefine therapeutic strategies against hematologic malignancies and beyond.

Salvatore Albani

Professor at Duke-NUS Medical School in Singapore and Director of the Translational Immunology Institute, he is an expert in the analysis and manipulation of human immunity to improve health. He has developed an advanced technological platform that integrates cytometry, single-cell RNA sequencing, and artificial intelligence to identify new therapeutic targets. Among his main contributions are the AI-driven architecture of the healthy immunome, CAR Tregs for autoimmunity, and a novel immunotherapy for rheumatoid arthritis. He is the author of over 100 patents and high-impact publications, with a strong entrepreneurial track record. He is also President of the Eureka Institute, dedicated to the training and promotion of translational medicine.

Faculty

Luigi Naldini

Director of the San Raffaele Telethon Institute for Gene Therapy and Professor at Vita-Salute San Raffaele University. He is a pioneer in the development of lentiviral vectors, now fundamental in gene therapy for genetic and oncological diseases. His research has led to new therapeutic strategies and discoveries on stem cells and angiogenesis. He has contributed to the advancement of gene editing and has published over 270 articles. He is a member of EMBO, former president of ESGCT, and advisor to international scientific committees. He has received numerous international awards, including the Jeantet-Collen Prize for Translational Medicine. In 2019, he was appointed Grand Officer of the Order of Merit of the Italian Republic.


The full faculty list will be announced shortly.

Useful Links